▶ 調査レポート

世界のシェーグレン症候群の治療薬市場：市場規模・現状・予測
• 英文タイトル：Global Sjogren's Syndrome Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のシェーグレン症候群の治療薬市場：市場規模・現状・予測 / Global Sjogren's Syndrome Therapeutics Market Size, Status and Forecast 2019-2025 / QYR9N8047資料のイメージです。• レポートコード：QYR9N8047
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、シェーグレン症候群の治療薬のグローバル市場について調査・分析したレポートで、種類別（一次、二次）、用途別（臨床、病院）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・シェーグレン症候群の治療薬の世界市場規模
・主要企業別市場シェア
・シェーグレン症候群の治療薬の世界市場規模：種類別（一次、二次）
・シェーグレン症候群の治療薬の世界市場規模：用途別（臨床、病院）
・シェーグレン症候群の治療薬のアメリカ市場規模（種類別、用途別）
・シェーグレン症候群の治療薬のヨーロッパ市場規模（種類別、用途別）
・シェーグレン症候群の治療薬の中国市場規模（種類別、用途別）
・シェーグレン症候群の治療薬の日本市場規模（種類別、用途別）
・シェーグレン症候群の治療薬の東南アジア市場規模（種類別、用途別）
・シェーグレン症候群の治療薬のインド市場規模（種類別、用途別）
・シェーグレン症候群の治療薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・シェーグレン症候群の治療薬の世界市場予測（2019年-2025年）
・シェーグレン症候群の治療薬の地域別市場予測（2019年-2025年）
...

Sjogren’s syndrome is an inflammatory disorder characterized by lymphocytic infiltrates in exocrine organs, primarily in lacrimal and salivary glands, resulting in classic sicca symptoms of dry mouth (xerostomia) and dry eyes (xerophthalmia). The disorder segmented into primary and secondary. The disorder that occurs in the absence of other autoimmune disease, such as lupus, rheumatoid arthritis, or scleroderma is known as primary Sjogren’s syndrome. The one that occurs due to presence of other autoimmune diseases is known as secondary Sjogren’s syndrome.
In 2018, the global Sjogren’s Syndrome Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Sjogren’s Syndrome Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sjogren’s Syndrome Therapeutics development in United States, Europe and China.

The key players covered in this study
Allergan
Biogen
Bristol-Myers Squibb
F. Hoffmann-La Roche
Novartis
Kissei Pharmaceutical
Aldeyra Therapeutics
GlaxoSmithKline
Biogen

Market segment by Type, the product can be split into
Primary
Secondary

Market segment by Application, split into
Clinical
Hospital

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Sjogren’s Syndrome Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Sjogren’s Syndrome Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sjogren’s Syndrome Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sjogren’s Syndrome Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Primary
1.4.3 Secondary
1.5 Market by Application
1.5.1 Global Sjogren’s Syndrome Therapeutics Market Share by Application (2014-2025)
1.5.2 Clinical
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Sjogren’s Syndrome Therapeutics Market Size
2.2 Sjogren’s Syndrome Therapeutics Growth Trends by Regions
2.2.1 Sjogren’s Syndrome Therapeutics Market Size by Regions (2014-2025)
2.2.2 Sjogren’s Syndrome Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Sjogren’s Syndrome Therapeutics Market Size by Manufacturers
3.1.1 Global Sjogren’s Syndrome Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Sjogren’s Syndrome Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sjogren’s Syndrome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Sjogren’s Syndrome Therapeutics Key Players Head office and Area Served
3.3 Key Players Sjogren’s Syndrome Therapeutics Product/Solution/Service
3.4 Date of Enter into Sjogren’s Syndrome Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Sjogren’s Syndrome Therapeutics Market Size by Type (2014-2019)
4.2 Global Sjogren’s Syndrome Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Sjogren’s Syndrome Therapeutics Market Size (2014-2019)
5.2 Sjogren’s Syndrome Therapeutics Key Players in United States
5.3 United States Sjogren’s Syndrome Therapeutics Market Size by Type
5.4 United States Sjogren’s Syndrome Therapeutics Market Size by Application

6 Europe
6.1 Europe Sjogren’s Syndrome Therapeutics Market Size (2014-2019)
6.2 Sjogren’s Syndrome Therapeutics Key Players in Europe
6.3 Europe Sjogren’s Syndrome Therapeutics Market Size by Type
6.4 Europe Sjogren’s Syndrome Therapeutics Market Size by Application

7 China
7.1 China Sjogren’s Syndrome Therapeutics Market Size (2014-2019)
7.2 Sjogren’s Syndrome Therapeutics Key Players in China
7.3 China Sjogren’s Syndrome Therapeutics Market Size by Type
7.4 China Sjogren’s Syndrome Therapeutics Market Size by Application

8 Japan
8.1 Japan Sjogren’s Syndrome Therapeutics Market Size (2014-2019)
8.2 Sjogren’s Syndrome Therapeutics Key Players in Japan
8.3 Japan Sjogren’s Syndrome Therapeutics Market Size by Type
8.4 Japan Sjogren’s Syndrome Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Sjogren’s Syndrome Therapeutics Market Size (2014-2019)
9.2 Sjogren’s Syndrome Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Sjogren’s Syndrome Therapeutics Market Size by Type
9.4 Southeast Asia Sjogren’s Syndrome Therapeutics Market Size by Application

10 India
10.1 India Sjogren’s Syndrome Therapeutics Market Size (2014-2019)
10.2 Sjogren’s Syndrome Therapeutics Key Players in India
10.3 India Sjogren’s Syndrome Therapeutics Market Size by Type
10.4 India Sjogren’s Syndrome Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Sjogren’s Syndrome Therapeutics Market Size (2014-2019)
11.2 Sjogren’s Syndrome Therapeutics Key Players in Central & South America
11.3 Central & South America Sjogren’s Syndrome Therapeutics Market Size by Type
11.4 Central & South America Sjogren’s Syndrome Therapeutics Market Size by Application

12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sjogren’s Syndrome Therapeutics Introduction
12.1.4 Allergan Revenue in Sjogren’s Syndrome Therapeutics Business (2014-2019)
12.1.5 Allergan Recent Development
12.2 Biogen
12.2.1 Biogen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sjogren’s Syndrome Therapeutics Introduction
12.2.4 Biogen Revenue in Sjogren’s Syndrome Therapeutics Business (2014-2019)
12.2.5 Biogen Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sjogren’s Syndrome Therapeutics Introduction
12.3.4 Bristol-Myers Squibb Revenue in Sjogren’s Syndrome Therapeutics Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 F. Hoffmann-La Roche
12.4.1 F. Hoffmann-La Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sjogren’s Syndrome Therapeutics Introduction
12.4.4 F. Hoffmann-La Roche Revenue in Sjogren’s Syndrome Therapeutics Business (2014-2019)
12.4.5 F. Hoffmann-La Roche Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sjogren’s Syndrome Therapeutics Introduction
12.5.4 Novartis Revenue in Sjogren’s Syndrome Therapeutics Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Kissei Pharmaceutical
12.6.1 Kissei Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sjogren’s Syndrome Therapeutics Introduction
12.6.4 Kissei Pharmaceutical Revenue in Sjogren’s Syndrome Therapeutics Business (2014-2019)
12.6.5 Kissei Pharmaceutical Recent Development
12.7 Aldeyra Therapeutics
12.7.1 Aldeyra Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sjogren’s Syndrome Therapeutics Introduction
12.7.4 Aldeyra Therapeutics Revenue in Sjogren’s Syndrome Therapeutics Business (2014-2019)
12.7.5 Aldeyra Therapeutics Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sjogren’s Syndrome Therapeutics Introduction
12.8.4 GlaxoSmithKline Revenue in Sjogren’s Syndrome Therapeutics Business (2014-2019)
12.8.5 GlaxoSmithKline Recent Development
12.9 Biogen
12.9.1 Biogen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sjogren’s Syndrome Therapeutics Introduction
12.9.4 Biogen Revenue in Sjogren’s Syndrome Therapeutics Business (2014-2019)
12.9.5 Biogen Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Sjogren's Syndrome Therapeutics Key Market Segments
Table Key Players Sjogren's Syndrome Therapeutics Covered
Table Global Sjogren's Syndrome Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Sjogren's Syndrome Therapeutics Market Size Market Share by Type 2014-2025
Figure Primary Figures
Table Key Players of Primary
Figure Secondary Figures
Table Key Players of Secondary
Table Global Sjogren's Syndrome Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinical Case Studies
Figure Hospital Case Studies
Figure Sjogren's Syndrome Therapeutics Report Years Considered
Table Global Sjogren's Syndrome Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Sjogren's Syndrome Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Sjogren's Syndrome Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Sjogren's Syndrome Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Sjogren's Syndrome Therapeutics Market Share by Regions 2014-2019
Figure Global Sjogren's Syndrome Therapeutics Market Share by Regions 2014-2019
Figure Global Sjogren's Syndrome Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Sjogren's Syndrome Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Sjogren's Syndrome Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Sjogren's Syndrome Therapeutics Market Share by Manufacturers in 2018
Table Global Sjogren's Syndrome Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Sjogren's Syndrome Therapeutics Product/Solution/Service
Table Date of Enter into Sjogren's Syndrome Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Sjogren's Syndrome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Sjogren's Syndrome Therapeutics Market Size Share by Type (2014-2019)
Figure Global Sjogren's Syndrome Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Sjogren's Syndrome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Sjogren's Syndrome Therapeutics Market Size Share by Application (2014-2019)
Figure Global Sjogren's Syndrome Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Sjogren's Syndrome Therapeutics Revenue Market Share by Application in 2018
Figure United States Sjogren's Syndrome Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Sjogren's Syndrome Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Sjogren's Syndrome Therapeutics Market Share (2018-2019)
Table United States Sjogren's Syndrome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Sjogren's Syndrome Therapeutics Market Share by Type (2014-2019)
Table United States Sjogren's Syndrome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Sjogren's Syndrome Therapeutics Market Share by Application (2014-2019)
Figure Europe Sjogren's Syndrome Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Sjogren's Syndrome Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Sjogren's Syndrome Therapeutics Market Share (2018-2019)
Table Europe Sjogren's Syndrome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Sjogren's Syndrome Therapeutics Market Share by Type (2014-2019)
Table Europe Sjogren's Syndrome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Sjogren's Syndrome Therapeutics Market Share by Application (2014-2019)
Figure China Sjogren's Syndrome Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Sjogren's Syndrome Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Sjogren's Syndrome Therapeutics Market Share (2018-2019)
Table China Sjogren's Syndrome Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Sjogren's Syndrome Therapeutics Market Share by Type (2014-2019)
Table China Sjogren's Syndrome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Sjogren's Syndrome Therapeutics Market Share by Application (2014-2019)
Figure Japan Sjogren's Syndrome Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Sjogren's Syndrome Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Sjogren's Syndrome Therapeutics Market Share (2018-2019)
Table Japan Sjogren's Syndrome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Sjogren's Syndrome Therapeutics Market Share by Type (2014-2019)
Table Japan Sjogren's Syndrome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Sjogren's Syndrome Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Sjogren's Syndrome Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Sjogren's Syndrome Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Sjogren's Syndrome Therapeutics Market Share (2018-2019)
Table Southeast Asia Sjogren's Syndrome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Sjogren's Syndrome Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Sjogren's Syndrome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Sjogren's Syndrome Therapeutics Market Share by Application (2014-2019)
Figure India Sjogren's Syndrome Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Sjogren's Syndrome Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Sjogren's Syndrome Therapeutics Market Share (2018-2019)
Table India Sjogren's Syndrome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Sjogren's Syndrome Therapeutics Market Share by Type (2014-2019)
Table India Sjogren's Syndrome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Sjogren's Syndrome Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Sjogren's Syndrome Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Sjogren's Syndrome Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Sjogren's Syndrome Therapeutics Market Share (2018-2019)
Table Central & South America Sjogren's Syndrome Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Sjogren's Syndrome Therapeutics Market Share by Type (2014-2019)
Table Central & South America Sjogren's Syndrome Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Sjogren's Syndrome Therapeutics Market Share by Application (2014-2019)
Table Allergan Company Details
Table Allergan Revenue in Sjogren's Syndrome Therapeutics Business (2014-2019) (Million US$)
Figure Allergan Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table Biogen Company Details
Table Biogen Revenue in Sjogren's Syndrome Therapeutics Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2014-2019)
Table Biogen Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Sjogren's Syndrome Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Sjogren's Syndrome Therapeutics Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Sjogren's Syndrome Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Kissei Pharmaceutical Company Details
Table Kissei Pharmaceutical Revenue in Sjogren's Syndrome Therapeutics Business (2014-2019)(Million US$)
Figure Kissei Pharmaceutical Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2014-2019)
Table Kissei Pharmaceutical Recent Development
Table Aldeyra Therapeutics Company Details
Table Aldeyra Therapeutics Revenue in Sjogren's Syndrome Therapeutics Business (2014-2019)(Million US$)
Figure Aldeyra Therapeutics Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2014-2019)
Table Aldeyra Therapeutics Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Sjogren's Syndrome Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Biogen Company Details
Table Biogen Revenue in Sjogren's Syndrome Therapeutics Business (2014-2019)(Million US$)
Figure Biogen Revenue Growth Rate in Sjogren's Syndrome Therapeutics Business (2014-2019)
Table Biogen Recent Development
Table Global Sjogren's Syndrome Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Sjogren's Syndrome Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Sjogren's Syndrome Therapeutics Market Size Share by Regions in 2025
Figure United States Sjogren's Syndrome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Sjogren's Syndrome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Sjogren's Syndrome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Sjogren's Syndrome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Sjogren's Syndrome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Sjogren's Syndrome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Sjogren's Syndrome Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Sjogren's Syndrome Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Sjogren's Syndrome Therapeutics Market Size by Product (2019-2025)
Figure Global Sjogren's Syndrome Therapeutics Market Size by Product in 2025
Table Global Sjogren's Syndrome Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Sjogren's Syndrome Therapeutics Market Size by Application (2019-2025)
Figure Global Sjogren's Syndrome Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界のクッシング症候群の治療市場：市場規模・現状・予測
    Global Cushing's Syndrome Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7049 2019年6月14日 93Pages
    当資料は、クッシング症候群の治療のグローバル市場について調査・分析したレポートで、種類別（グルココルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...
  • 世界の多嚢胞性卵巣症候群市場：市場規模・現状・予測
    Global Polycystic Ovary Syndrome Market Size, Status and Forecast 2019-2025
    QYR9N7858 2019年6月14日 106Pages
    当資料は、多嚢胞性卵巣症候群のグローバル市場について調査・分析したレポートで、種類別（利尿薬、インスリン増感剤、抗アンドロゲン剤、抗うつ薬、オルニチンデカルボキシラーゼ阻害剤、その他）、用途別（病院薬局、ドラッグストア、小売薬局、不妊治療クリニック、電子商取引）、主要地域別（アメリカ、ヨーロッパ、中...
  • 世界のプラダーウィリー症候群治療薬市場2019
    Global Prader-Willi Syndrome Therapeutics Sales Market Report 2019
    QYR9N3709 2019年6月13日 107Pages
    本調査レポートでは、プラダーウィリー症候群治療薬の世界市場について調査・分析し、プラダーウィリー症候群治療薬のメーカー別販売量、市場シェア分析、種類別販売分析（ベロラニブ、ベタヒスチン塩酸塩、ジアゾキシドコリンCR、FE-992097、NOX-B11、その他）、用途別販売分析（診療所、病院、その他）...
  • 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測
    Global Myelodysplastic Syndrome (MDS) Drugs Market Size, Status and Forecast 2019-2025
    QYR9N7611 2019年6月14日 96Pages
    当資料は、骨髄異形成症候群（MDS）薬のグローバル市場について調査・分析したレポートで、種類別（低メチル化剤、免疫調節薬、抗貧血薬）、用途別（オリジナル、ジェネリック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...
  • 世界の周期性発熱症候群市場：市場規模・現状・予測
    Global Periodic Fever Syndrome Market Size, Status and Forecast 2019-2025
    QYR9N7792 2019年6月14日 96Pages
    当資料は、周期性発熱症候群のグローバル市場について調査・分析したレポートで、種類別（高免疫グロブリン血症D症候群、家族性地中海熱、TNF受容体関連周期性症候群、クリオピリン関連周期症候群、その他）、用途別（病院、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の...
  • 世界のパリーロンバーグ症候群市場：市場規模・現状・予測
    Global Parry-Romberg Syndrome Market Size, Status and Forecast 2019-2025
    QYR9N7769 2019年6月14日 99Pages
    当資料は、パリーロンバーグ症候群のグローバル市場について調査・分析したレポートで、種類別（健康診断、MRIスキャン、血清検査）、用途別（病院と診療所、理学療法士）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のセロトニン症候群市場：市場規模・現状・予測
    Global Serotonin Syndrome Market Size, Status and Forecast 2019-2025
    QYR9N8021 2019年6月14日 96Pages
    当資料は、セロトニン症候群のグローバル市場について調査・分析したレポートで、種類別（セロトニン拮抗薬、支持療法、消化管除染、その他）、用途別（病院での使用、診療所での使用、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含ま...
  • 世界の多嚢胞性卵巣症候群の治療市場：市場規模・現状・予測
    Global Polycystic Ovarian Syndrome Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7857 2019年6月14日 99Pages
    当資料は、多嚢胞性卵巣症候群の治療のグローバル市場について調査・分析したレポートで、種類別（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、その他）、用途別（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南ア...
  • 世界のQT延長症候群の治療市場：市場規模・現状・予測
    Global Long QT Syndrome Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7468 2019年6月14日 90Pages
    当資料は、QT延長症候群の治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・QT...
  • 世界のスタージウェーバー症候群（SWS）治療市場：市場規模・現状・予測
    Global Sturge Weber Syndrome (SWS) Treatment Market Size, Status and Forecast 2019-2025
    QYR9N8087 2019年6月14日 98Pages
    当資料は、スタージウェーバー症候群（SWS）治療のグローバル市場について調査・分析したレポートで、種類別（薬、レーザー治療、外科処置）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含ま...
  • 世界のプラダーウィリー症候群治療薬市場2019世界のプラダーウィリー症候群治療薬市場2019 The global Prader-Willi Syndrome Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Prader-Willi Syndrome Therapeutics market status and forecast, categorizes the global Prader-Wil…
  • 世界のクッシング症候群の治療市場：市場規模・現状・予測世界のクッシング症候群の治療市場：市場規模・現状・予測 Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia.In terms of …
  • 世界の多嚢胞性卵巣症候群市場：市場規模・現状・予測世界の多嚢胞性卵巣症候群市場：市場規模・現状・予測 Polycystic ovary syndrome is a hormonal disorder observed in females of reproductive ages.Initiatives taken by the government and non-profit organizations to spread awareness regarding the early diagnosis of the disorder is significantly fueling the market growth. Moreover, increasing genetic and ho…
  • 世界のドラヴェット症候群治療薬市場2019世界のドラヴェット症候群治療薬市場2019 The global Dravet Syndrome Thereapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Dravet Syndrome Thereapeutics market status and forecast, categorizes the global Dravet Syndrome Ther…
  • 世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測 Myelodysplastic syndrome is caused by mutation of one or more genes that control development of blood cells. It is one of the most common malignant hematological diseases that affects five out of every 100,000 people in U.S. annually. An estimated 60,000 people in U.S. live with MDS, and approximate…